Chinese Traditional and Herbal Drugs
|
2025, 56(18): 6644-6656
Mechanism of paeonol on mice with alcoholic liver disease based on network pharmacology and experimental verification
Full
WANG Zining1, PU Hao1, WANG Qingru1, YAN Guiming2,3
Affiliations
1 School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China; 2 School of Nursing, Anhui University of Chinese Medicine, Hefei 230012, China; 3 Geriatric Care and Health Laboratory, Anhui University of Chinese Medicine, Hefei 230012, China
About Author:
安徽省自然科学基金资助项目 (2022AH050521)
doi: 10.7501/j.issn.0253-2670.2025.18.014
Outline
Objective To explore the effect and mechanism of paeonol in treatment of alcoholic liver disease (ALD) based on network pharmacology, molecular docking and animal experiments. Methods PharmMapper data platform was utilized to retrieve targets related to paeonol. ALD related genes were screened from DisGeNET, GeneCards and OMIM disease databases, ALD chips was obtained by searching GEO databases and screening for differentially expressed genes, disease-related gene modules was screened based on WGCNA, ALD related genes was obtained by analyzing the intersection of genes from disease databases, differentially expressed genes and WGCNA derived genes, and then intersecting with paeonol targets to obtain relevant targets for paeonol in treatment of ALD, correlation analysis and gene ontology (GO) function and Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analysis were performed, least absolute shrinkage and selection operator (LASSO) regression was used to screen targets, followed by molecular docking validation. The Lieber DeCarli alcohol liquid feed free diet method was used to establish an ALD mouse model. Control group, model group, silibinin (36.8 mg/kg) group, and paeonol high-, low-dose (480, 120 mg/kg) groups were set up, with eight mice in each group, and drugs were administered for intervention. The pharmacological effect was evaluated by detecting blood lipid levels, liver function indexes and levels of inflammatory factors. Hematoxylin-eosin (HE) and oil red O staining were used to observe pathological changes in liver. Western blotting and qRT-PCR were used to detect the expression levels of fatty acid binding protein 4 (FABP4), peroxisome proliferator activated receptor alpha (PPARα) and carnitine palmitoyltransferase 1A (CPT1A) in liver tissue. Results A total of 88 drug targets, 516 disease targets and 13 intersecting targets were screened. A total of 835 biological functions and 70 pathways were obtained by GO and KEGG enrichment analysis. Seven targets were screened by LASSO regression algorithm. Molecular docking results showed that the binding energies of paeonol to FABP4 and PPARα were less than −5 kcal/mol. The results of animal experiments showed that compared with control group, levels of liver function indexes, blood lipid levels and inflammatory factors in model group mice were significantly increased (P < 0.01, 0.001), inflammation infiltration and fat vacuoles were appeared in liver tissue. Compared with model group, paeonol improved the levels of liver function indexes, blood lipid levels and inflammatory factors in mice (P < 0.05, 0.01, 0.001), restored the normal structure of liver cells, and reduced hepatic fat vacuoles. Western blotting and qRT-PCR results showed that compared with control group, the protein and mRNA expression levels of FABP4 in liver tissue of model group mice were significantly increased (P < 0.01, 0.001), while the protein and mRNA expression levels of PPARα and CPT1A were significantly decreased (P < 0.001). Compared with model group, paeonol significantly reduced the protein and mRNA expression levels of FABP4 (P < 0.05, 0.001), and up-regulated the protein and mRNA expression levels of PPARα and CPT1A (P < 0.05, 0.01). Conclusion Paeonol improves lipid metabolism by down-regulating FABP4 and up-regulating PPARα and CPT1A expressions.
paeonol
/
alcoholic liver disease
/
lipid metabolism
/
FABP4
/
PPARα
/
CPT1A
王紫柠, 蒲浩, 王清如, 颜贵明.
基于网络药理学和实验验证探讨丹皮酚对酒精性肝病小鼠的作用机制.
中草药,
2025
, 56
(18)
: 6644
-6656
.
DOI: 10.7501/j.issn.0253-2670.2025.18.014
WANG Zining, PU Hao, WANG Qingru, YAN Guiming.
Mechanism of paeonol on mice with alcoholic liver disease based on network pharmacology and experimental verification[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(18)
: 6644
-6656
.
DOI: 10.7501/j.issn.0253-2670.2025.18.014
Year 2025 volume 56 Issue 18
56
0
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.18.014
- Receive Date:2025-05-27
- Online Date:2026-11-12